Jasjot Singh has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.8 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jasjot Singh, a promoter of Ajooni Biotech Limited, has submitted a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to the exchange. This regulation requires promoters to disclose details of any encumbrance (such as pledge or lien) created on their shares in the company. The filing indicates the promoter's compliance with takeover regulations, but the specific contents of the disclosure (whether shares are encumbered or not) are not detailed in this announcement. No change in shareholding or stake value is mentioned in the filing.
This appears to be a routine regulatory compliance filing and is unlikely to have any direct impact on the stock price or shareholders. Investors should look for the actual disclosure document to check if the promoter has pledged or encumbered any shares.